Real-time enrollment status for this acute leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:30 PM UTC
| NCT Number | NCT06615050 |
| Recruiting Status | Recruiting |
| Condition | Acute Leukemia |
| Phase | PHASE3 |
| Target Enrollment | 572 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 17, 2026: Clinical trial NCT06615050 is currently recruiting participants. This phase3 study for acute leukemia is actively seeking new participants at 30 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06615050 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06615050 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.